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Clinical Application of Liver MR Imaging
in Wilson’s Disease
Objective: To determine whether there is a correlation between liver MR find-
ings and the clinical manifestations and severity of liver dysfunction in patients
with Wilson’s disease.
Materials and Methods: Two radiologists retrospectively evaluated MR
images of the liver in 50 patients with Wilson’s disease. The Institutional Review
Board approved this retrospective study and informed consent was waived. MR
images were evaluated with a focus on hepatic contour abnormalities and the
presence of intrahepatic nodules. By using Fisher’s exact test, MR findings were
compared with clinical presentations (neurological and non-neurological) and
hepatic dysfunction, which was categorized by the Child-Pugh classification sys-
tem (A, B and C). Follow-up MR images were available for 17 patients.
Results: Contour abnormalities of the liver and intrahepatic nodules were
observed in 31 patients (62%) and 25 patients (50%), respectively. Each MR find-
ing showed a statistically significant difference (p < 0.05) among the three groups
of Child-Pugh classifications (A, n = 36; B, n = 5; C, n = 9), except for
splenomegaly (p = 0.243). The mean age of the patients with positive MR find-
ings was higher than that of patients with negative MR findings. For patients with
Child-Pugh class A (n = 36) with neurological presentation, intrahepatic nodules,
surface nodularity, and gallbladder fossa widening were more common.
Intrahepatic nodules were improved (n = 8, 47%), stationary (n = 5, 29%), or
aggravated (n = 4, 24%) on follow-up MR images.
Conclusion: MR imaging demonstrates the contour abnormalities and
parenchymal nodules of the liver in more than half of the patients with Wilson’s
disease, which correlates with the severity of hepatic dysfunction and clinical
manifestations. 
ilson’s disease or progressive hepatolenticular degeneration is an autoso-
mal recessive disorder of copper metabolism (1). The gene that causes
Wilson’s disease, located at chromosome 13 band q14.3, is known to
code for a copper-transporting P-type ATPase (2-4). A mutation of the gene associ-
ated with Wilson’s disease results in deficient biliary excretion of copper, leading to
excessive copper accumulation in many tissues. Copper accumulation occurs mainly in
the liver, but also in the brain, cornea, and kidney (1-5). The principal clinical manifes-
tations of Wilson’s disease are either hepatic or neurological disease (6, 7). 
Ultrasound (US), CT, and MR findings of the liver in Wilson’s disease usually reflect
nonspecific hepatic injury including fatty infiltration, acute hepatitis, chronic active
hepatitis, and cirrhosis (8-12). In advanced Wilson’s disease, nodular infiltrations
suggesting the presence of copper-containing nodules and contour abnormalities consis-
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Wtent with cirrhosis have been reported in the literature (12-
14). However, the clinical applications of MR imaging
features of the liver in Wilson’s disease have not yet been
established. The purpose of this study was to evaluate the
morphological features of the liver on MR images obtained
in patients with Wilson’s disease, and determine whether
there is a correlation between the MR findings and clinical
manifestations and severity of hepatic dysfunction.
MATERIALS AND METHODS
Patients
MR images of the liver were retrospectively reviewed
alongside clinical findings in 50 children and young adults
with Wilson’s disease (M:F = 33:17; age range, 5-26 years;
median age, 14 years). The database of the computed
hospital information system was cross-referenced with the
MR imaging database to identify all patients with Wilson’s
disease who had undergone MR imaging of the liver at the
institution over the course of a 10-year period from
January 1997 to January 2007. The institutional review
board approved the review of the radiological and clinical
data for this study and waived the requirement for patient
informed consent. Wilson’s disease was diagnosed based
on a combination of low serum ceruloplasmin levels
accompanied with elevated 24-hour urinary copper
excretion (n = 50), as well as the presence of a Kayser-
Fleischer (K-F) ring (n = 28), and a liver biopsy (n = 12). 
Patients were classified at the time of diagnosis as having
neurological (either current clinical or historical evidence
of neurological dysfunction which was not associated with
symptomatic liver disease) and non-neurological presenta-
tion, including hepatic (an increase in serum transaminase
levels, acute/chronic hepatitis or cirrhosis) and asympto-
matic presentation (siblings of index cases with no disease-
related symptoms) (6). The hepatic function of the each
patient was categorized into three groups (class A, B and
C) according to the Child-Turcotte-Pugh score (5 to 15-
point scale) (15). 
Twenty-two patients had been treated with copper
chelators, D-penicillamine (n = 16), or trientine (n = 6)
(median duration of treatment: 6 years, range: 0.5-12
years) at the time of MR imaging. Another 28 patients
were diagnosed with Wilson’s disease at the time of MR
imaging and was administered any copper chelating agents.
The clinical characteristics of the patients were
summarized in Table 1. All patients were followed at the
pediatric outpatient clinic, and follow-up MR images were
available for 17 patients. 
MR Imaging
All examinations were obtained using 1.0 or 1.5 Tesla
MR scanners (Siemens Medical Systems, Erlangen,
Germany). This retrospective data collection was preceded
by the various MR imaging protocols for the liver.
However, the studies included the following MR
sequences: an axial T2-weighted fast spin-echo sequence
(repetition time msec/echo time msec, 3500-5000/96-144)
and an axial T1-weighted spin echo sequence (repetition
time msec/echo time msec, 410-530/1.5-2.2) with a 7 mm
thickness, 1-2-mm gap, 256 × 256 matrix size and field-
of-view, 240 × 320.
Cheon et al.
666 Korean J Radiol 11(6), Nov/Dec 2010
Fig. 1. Interpretation of intrahepatic nodules in Wilson’s disease on T2-weighted images (TR/TE = 3500/100)
A. 9-year-old girl with Wilson’s disease and elevated liver enzymes (Child-Pugh class A) shows innumerable tiny, hypointense nodules
(≤ 3 mm in diameter, grade 1) in liver on T2-weighted image.
B. 24-year-old woman with Wilson’s disease who presented with jaundice (Child-Pugh class B) shows innumerable hypointense nodules
(> 3 mm in diameter, grade 2) on T2-weighted image.
ABMR Imaging Analysis
Two radiologists, each with more than seven years of
experience in MR body imaging, retrospectively evaluated
the MR images. The radiologists were blinded to the
clinical and pathological findings. The two readers
evaluated the MR images for (a) the presence and pattern
of intrahepatic nodules, (b) the contour abnormalities of
the liver and (c) additional findings such as a gallbladder
abnormality, splenomegaly, venous collateral formation, or
ascites.
A three-point scoring system was used to evaluate the
pattern of intrahepatic nodules as follows: 0 for none, 1 for
granular (≤ 3 mm in diameter), and 2 for macronodular 
(> 3 mm in diameter) (Fig. 1). We evaluated the signal
intensity of the nodules on T1-weighted images in compari-
son to the underlying liver parenchyma. The various
contour abnormalities of the liver identified included
surface nodularity, gallbladder fossa widening, and caudate
hypertrophy. Surface nodularity of the liver and the
gallbladder fossa widening were assessed subjectively by
the evaluation of irregularities along the liver surface and
enlargement of the pericholecystic space (i.e., the gallblad-
der fossa), respectively. Caudate hypertrophy was
evaluated using a modified caudate-right lobe ratio (16). 
Twenty follow-up MR examinations obtained from 17
patients over a 10-year period (mean interval 28 months,
range, 8-130 months) were also evaluated with the same
MR interpretation protocols. Nine patients underwent MR
imaging, before and after treatment, using copper chelating
agents. In the eight remaining patients, both initial and
follow-up MR examinations were obtained during
treatment with copper chelating agents. 
Statistical Analysis
The prevalence of the MR imaging findings was
estimated as a percentage of the patients displaying each
abnormality. The overall association between the MR
findings and clinical presentations (neurological or non-
neurological), or severity of hepatic dysfunction (Child-
Pugh classification A, B, C), was assessed with a contin-
gency table, employing the Chi-squared and Fisher’s exact
tests. The association of clinical features for both clinical
presentations was also evaluated by Chi-squared and
Fisher’s exact probability tests. Differences in age and
duration of treatment were compared for both groups of
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Table 1. Clinical Characteristics of 50 Patients with Wilson’s
Disease
Clinical Presentation
Neurological  Non-Neurological P value
(n = 12) (n = 38)
Male/female ratio 7:5 26:12 0.728
Age (years) 
at diagnosis 13.8±1.9 11.9±5.9 0.093
at MR examination 14.6±2.3 13.6±6.2 0.539
Kayser-Fleischer ring 11 (92%) 17 (45%) 0.006
Hepatic Function 0.048
Child-Pugh class A 12 (100%) 24 (63%)
Child-Pugh class B 0 5 (13%)
Child-Pugh class C 0 9 (24%)
Treatment
Untreated/treated 7:5 21:17 0.852
Duration of  2.8±1.8 6.2±3.8 0.120
treatment (years)
Fig. 2. 11-year-old girl diagnosed with Wilson’s disease (Child-Pugh class A).
A. T2-weighted axial image shows multiple small hypointense nodules (≤ 3 mm in diameter, grade 1) in liver.
B. Follow-up T2-weighted axial image obtained 18 months after D-penicillamine treatment shows near disappearance of hypointense
nodules in liver.
ABclinical presentation, three groups of hepatic dysfunction,
and type of MR finding using non-parametric probability
tests (Mann-Whitney or Kruskal-Wallis). All p-values were
based on two tailed comparisons and a 5% confidence-
level was considered to indicate a statistically significant
difference. Statistical analyses were performed with SPSS
7.5 for Windows (SPSS, Chicago, IL).
RESULTS
Clinical Features
At the time of diagnosis, 12 patients presented with
neurological dysfunction, compared to 38 patients who
presented with non-neurological manifestations (33
patients with hepatic dysfunction and five asymptomatic
siblings of index cases). The K-F ring was most common in
the neurological presentation (92%, 11 of 12) relative to
non-neurological presentation (45%; 17 of 38; p = 0.006).
There were no statistically significant differences between
sex, age, presence of medical treatment, and duration of
treatment among both clinical presentations (Table 1). 
Patient hepatic function was categorized as Child-Pugh
class A in 36 patients, Child-Pugh class B in five patients,
and Child-Pugh class C in nine patients. Mean age at
diagnosis was 11.1 years in class A, 13.4 years in class B,
and 17.0 years in class C. A statistically significant differ-
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Fig. 3. 11-year-old boy with Wilson’s disease (Child-Pugh class B)
A. T2-weighted image shows mild irregularity of liver surface and  multiple, hypointense nodules in liver. 
B. These macronodular lesions show hyperintensities on T1-weighted images.
AB
Table 2. Association Between Liver MR Imaging and Hepatic Dysfunction
Liver MR Findings
No. of  Child-Pugh Classification
Patients  A (n = 36) B (n = 5) C (n = 9)
P value
Intrahepatic nodule 
Hypointense nodules on T2WI 25 (50%) 12 (33%) 5 (100%) 8 (89%) < 0.001
Grade 1  13 (26%) 9 (25%) 2 (40%) 2 (22%)
Grade 2  12 (24%) 3 (8%) 3 (60%) 6 (67%)
Hyperintense nodules on T1WI  14 (28%) 6 (17%) 4 (80%) 4 (44%) 0.004
Hepatic Contour
Surface nodularity  25 (50%) 13 (36%)  4 (80%) 8 (89%) 0.006
Caudate hypertrophy  10 (20%) 2 (6%) 3 (60%) 5 (56%) < 0.001
Gallbladder fossa widening  29 (58%) 17 (47%)  5 (100%) 7 (78%)  0.031
Others
Ascites  7 (14%) 1 (3%) 1 (20%) 5 (56%) 0.001
Venous collaterals  10 (20%) 3 (8%) 1 (20%) 6 (67%) 0.012
Gallbladder wall edema  12 (24%) 2 (6%) 3 (60%) 7 (78%) < 0.001
Splenomegaly  40 (80%) 27 (75%)  4 (80%) 9 (100%) 0.243
Note.─ Grade 1 = granular nodules (≤ 3 mm in diameter), Grade 2 = macronodular lesions (> 3 mm in diameter), SI = signal intensity, T1WI = T1-
weighted images, T2WI = T2-weighted imagesence was noted for age at MR imaging among the three
groups of Child-Pugh classification (p = 0.036). All of the
patients with a neurological presentation were categorized
as class A. Another 38 patients with non-neurological
presentation were categorized as class A (n = 24, 63%),
class B (n = 5, 13%), and class C (n = 9, 24%). There was a
statistically significant difference for Child-Pugh classifica-
tion between neurological and non-neurological presenta-
tions (p = 0.048). The clinical findings of 50 patients are
summarized in Table 1.
MR Imaging Findings 
Twenty-five patients (50%) demonstrated hypointense
hepatic nodules on T2-weighted images. The nodules were
granular (grade 1, ≤ 3 mm in diameter) in 13 patients
(Figs. 1A, 2A), or macronodular (grade 2, > 3 mm in
diameter) in 12 patients (Figs. 1B, 3A, 4A). These nodules
were hyperintense (n = 14) or isointense, or slightly
hypointense (n = 11) as seen on T1-weighted images (Figs.
3B, 4B). Thirty-one patients (62%) showed contour
abnormalities such as surface nodularity (n = 25), caudate
hypertrophy (n = 10), or gallbladder fossa widening 
(n = 29) (Figs. 3, 4). Ascites, venous collaterals, and
splenomegaly were observed in seven patients, 10 patients,
and 40 patients, respectively. Edematous wall thickening
of the gallbladder was observed in 12 patients, and a
gallbladder stone or sludge in three patients (Fig. 4).
Clinical Correlation of MR Imaging Findings 
In the 36 patients belonging to Child-Pugh class A,
hypointense nodules as seen on T2-weighted images, were
detected in 12 patients (33%) (grade 1 [n = 9, 25%] and
grade 2 [n = 3, 8%]). Contour abnormalities of the liver
were noted in 17 patients (47%). In the five patients
categorized as Child-Pugh class B, hypointense nodules as
seen on T2-weighted images, and contour abnormalities of
the liver were detected in all patients. Macronodular
lesions (grade 2, > 3 mm in diameter) were observed in
three patients (60%) (Fig. 3). In the nine patients catego-
rized as Child-Pugh class C, hypointense nodules as seen
on T2-weighted images and contour abnormalities of the
liver were noted in all patients except for one (89%).
Wilson’s Disease and Clinical MR Imaging Application
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AB
Fig. 4. 24-year-old man with Wilson’s disease and advanced
cirrhosis (Child-Pugh class C).
A. Disseminated hyperintense nodules greater than 1 cm in size
relative to liver parenchyma are seen on axial T2-weighted MR
image. Note surface irregularity and parenchymal contraction of
liver.
B. T1-weighted axial image of liver shows multiple hyperintense
nodules. Gallbladder stone (arrow) is seen as nodular hyperinten-
sity near porta hepatis.
C. Harvested liver during liver transplantation shows macronodular
cirrhosis. There was no evidence of hepatocellular carcinoma.
CMacronodular lesions were observed in six patients (67%)
(Fig. 4). Each MR imaging finding demonstrated a statisti-
cally significant difference among the three groups of
Child-Pugh classification except for splenomegaly (p =
0.243). A summary of the MR findings and association of
MR findings with the severity of hepatic dysfunction are
listed in Table 2. For each MR imaging finding, mean age
at MR examination was greater in patients with a positive
finding than those with negative findings, and were statisti-
cally significant except in hyperintense nodules on T1-
weighted images (p = 0.113) (Table 3).
In the patients belonging to Child-Pugh class A (n = 36),
MR findings such as intrahepatic nodules (p = 0.007),
surface nodularity (p = 0.011), and gallbladder fossa
widening (p < 0.001) demonstrated a statistically signifi-
cant difference between patients with neurological presen-
tation and non-neurological presentation. Other MR
findings did not present a statistically significant difference
between neurological presentation and non-neurological
presentation (Table 4).
Follow-Up MR Imaging Findings and Clinical
Features
Twenty follow-up MR examinations obtained from 17
patients demonstrated improved hepatic nodular infiltra-
tions for eight patients, aggravated intrahepatic nodules
and/or cirrhosis for four patients, and a stationary state of
imaging features for five patients (Fig. 2B). In the eight
patients with improved nodular lesions, all of them showed
improved hepatic dysfunction (normalized serum transami-
nase level, n = 5; improved hyperbilirubinemia, n = 1;
improved coagulation abnormality, n = 2). In four patients
with aggravated nodular lesions and/or cirrhosis, newly
appeared intrahepatic nodules were detected in two
patients, whereas aggravated intrahepatic nodules and
cirrhosis were observed in two patients. Among these four
patients, two patients underwent liver transplantation (Fig.
4C).  
DISCUSSION
In Wilson’s disease, asymptomatic hepatic copper deposi-
tion in liver cells occurs early in the disease’s progression,
predominantly in the periportal regions and along the
hepatic sinusoids (17, 18). After episodes of acute hepatitis,
which may be reflected by elevated plasma levels of liver
enzymes, a fatty change and periportal inflammation can
develop. Afterwards, piecemeal necrosis and fibrosis with
inflammatory cell infiltrations induce chronic active hepati-
tis. Finally, after several years, insidious development of
irreversible cirrhosis occurs (19). In a large cohort study of
patients with Wilson’s disease, liver biopsies revealed
variable hepatic involvement in 37% of patients presenting
cirrhosis, 36% at an unspecified stage of fibrosis, and 54%
with steatosis (20). 
Considering the variable hepatic involvement, various
imaging findings of the liver in Wilson’s disease are
demonstrated (8-13). Recently, Akhan et al. (14) reported
that Wilson’s disease should be considered as one of the
leading diagnoses of young patients with a perihepatic fat
Cheon et al.
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Table 3. Association of Liver MR Imaging and Age at MR
Examination
Liver MR Findings
Mean Age (± Standard Deviation)
Positive Negative P value
Intrahepatic nodule 
Hypointense nodules  15.8 ± 4.6 11.9 ± 5.8 0.001
on T2WI
Hyperintense nodules  16.1 ± 5.4 12.9 ± 5.4 0.113
on T1WI 
Hepatic Contour
Surface nodularity  16.4 ± 4.8 11.2 ± 5.1 < 0.001
Caudate hypertrophy  19.5 ± 3.8 12.4 ± 5.0 < 0.001
Gallbladder fossa  16.2 ± 4.6 10.6 ± 5.1 0.001
widening 
Others
Ascites  20.3 ± 6.7 12.8 ± 4.6 0.006
Venous collaterals  18.6 ± 6.4 12.7 ± 4.9 0.013
Gallbladder wall  17.6 ± 6.4 12.6 ± 4.7 0.025
edema 
Splenomegaly  15.2 ± 5.1 08.4 ± 3.8 < 0.001
Table 4. Association of Liver MR Imaging and various
Clinical Manifestations
Liver MR Findings in Clinical Presentation
Patients with  Neurological Non- 
Child-Pugh Class A  (n = 12) Neurological
P value
(n = 36) (n = 24)
Intrahepatic nodules
Hypointensity on T2WI 08 (67%) 04 (17%) 0.007
Hyperintense on T1WI 04 (33%) 2 (8%) 0.149
Hepatic Contour
Surface nodularity  08 (67%) 05 (21%) 0.011
Caudate hypertrophy  0  2 (8%) 0.543
Gallbladder fossa 
widening 11 (92%) 06 (25%) < 0.001
Others
Ascites  0 1 (4%) 1.000
Venous collaterals  1 (8%) 2 (8%) 1.000
Gallbladder wall edema  0 2 (8%) 0.543
Splenomegaly  11 (92%) 016 (67%)0 0.108layer, parenchymal heterogeneity with multiple nodules,
and the absence of caudate lobe hypertrophy. It also
suggested that US seemed to be the best imaging modality
for the demonstration of early parenchymal alteration. In
this study, hypointense nodules on T2-weighted images,
surface nodularity of the liver, and gallbladder fossa
widening were common MR imaging findings in patients
with Wilson’s disease, and these correlated with severity of
hepatic dysfunction. Among the patients with normal or
mild hepatic dysfunction (Child-Pugh class A), the MR
findings were more common in patients with the neurologi-
cal manifestations than the non-neurological manifestations
of Wilson’s disease. Therefore, it is postulated that
neurological dysfunction, which was not associated with
symptomatic liver disease, might  be related with hepatic
copper accumulation and subsequent hepatic parenchymal
changes. 
Hepatic nodules in Wilson’s disease are considered as a
result of copper deposition. On MR imaging, these lesions
typically appear as hypointense on T2-weighted images
and hyperintense on T1-weigthed images (9, 14). In this
study, multiple hypointense nodules were commonly noted
on T2-weighted images (50%). The paramagnetic effect of
ionic copper has been implicated as a cause of hypointen-
sity, as was observed on T2-weighted images and hyperin-
tensity as observed on T1-weighted images. However, the
T1-shortening and T2-shortening effect of copper deposi-
tion may be nullified by elevated T1 and T2 values in
advanced cirrhosis (17). Multiple hypoinstense nodules of
the liver were noted in 33% of patients with early stage of
hepatic dysfunction (Child-Pugh class A) before advanced
cirrhosis. In patients with advanced hepatic dysfunction
(Child-Pugh classes B and C), hypointense nodules of the
liver were noted in 93% (13 of 14) of the patients and
50% of the nodules were macronodular (> 3 mm in
diameter) and were observed as hyperintense on T1-
weighted images. 
Contour abnormalities of the liver due to parenchymal
necrosis, regeneration, and scarring that suggest cirrhosis
were correlated with hepatic dysfunction in this study. The
expanded gallbladder fossa sign has been reported to be a
highly specific MR sign for the diagnosis of cirrhosis, and
consists of the enlargement of the pericholecystic space
(i.e., the gallbladder fossa) (21). This is comparable to the
finding of a thickened perihepatic fat layer as described by
Akhan et al. (10). A normal caudate to right lobe ratio has
been reported as a unique feature of cirrhosis in Wilson’s
disease (14). In this study, caudate hypertrophy was less
common (20% of patients) relative to other imaging
features that were suggestive of cirrhosis. However, an
explanation is not postulated for the mechanism of lobar
dysmorphism of the liver in these patients.
Reversibility of copper deposition after copper chelating
therapy is noteworthy. Kim et al. (22) reported that MR
imaging of the brain depicts the reversible changes of the
involved brain parenchyma after copper chelating therapy.
Reversible changes of copper deposition in the liver have
been rarely reported (12, 14, 23). In this study, follow-up
MR images of the liver demonstrated improved intrahep-
atic nodules in 47% (8 of 17) of patients after copper
chelating therapy with clinical improvement of liver
function. Follow-up MR examinations also demonstrated
aggravated nodular infiltrations and progressed contour
abnormalities of cirrhosis in four patients with rapidly
progressive hepatic dysfunction. From this point of view,
MR imaging may be used as an indicator of therapeutic
response in Wilson’s disease.
This study has several limitations. First, clinical grading
of Wilson’s disease has not yet been fully established. The
Child-Pugh classification was used in the evaluation of
clinical status of Wilson’s disease, which only reflects
hepatic dysfunction. Serum ceruloplasmin and copper
levels, as well as the 24-hour urinary copper level were not
considered. Although 50 patients with Wilson’s disease
were included in the study, most of the patients were
Child-Pugh class A, and only 25% of the patients were
Child-Pugh class B or C. Therefore, an error in the statisti-
cal analysis was inevitable. Second, the MR protocol could
not be uniformly assumed, as the study included retrospec-
tive data collection for a 10-year span. Third, interobserver
or intraobserver variance analyses were not performed for
the MR imaging interpretation.
In conclusion, MR imaging of the liver in Wilson’s
disease demonstrated multiple, hypointense nodules on
T2-weighted images, as well as contour abnormalities of
the liver suggestive of cirrhosis. These imaging features
correlated with the severity of hepatic dysfunction and
clinical presentation. MR imaging also demonstrated
reversible parenchymal changes after clinical improve-
ment.
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